Genera Biosystems

Genera Biosystems is a spin-off from Australia's top research institution, the Walter and Eliza Hall Institute of Medical Research, and is a publicly listed company. It develops and commercializes multiplex molecular diagnostic tests based on its proprietary AmpaSand technology. Genera Biosystems' products compete in the global molecular diagnostics testing market and are used by commercial pathology providers. AmpaSand beads are an ideal platform for medium-density multiplex testing (5-150 analytes) in pathology laboratories. We are committed to providing doctors and their patients with accurate, clinically relevant molecular diagnostic assays.